Clinical Trial Update: Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14 [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating buprenorphine/naloxone for heroin dependence has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence
• Substance-related Disorders

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Opioid Dependence, Substance-Related Disorders | Phase 4 | Status: COMPLETED